The Stomach in Diabetes: From Villain to Ally

被引:22
作者
Camilleri, Michael [1 ]
机构
[1] Mayo Clin, Miles & Shirley Fiterman Ctr Digest Dis, Coll Med, CENTER, Rochester, MN 55905 USA
关键词
GASTROINTESTINAL-TRACT; MELLITUS; GASTROPARESIS; SYMPTOMS; SURGERY; LIFE;
D O I
10.1016/j.cgh.2008.10.031
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
The stomach is commonly the source of chronic digestive symptoms in patients with diabetes mellitus; erratic stomach emptying may result in poor glycemic control.. On the other hand, medications that mimic or enhance the function of the endogenous incretins retard gastric emptying to enhance glycemic control. In patients with obesity and type 2 diabetes, bariatric procedures alter food intake and weight; however, effects on glycemic control precede and are out of proportion with the degree of weight loss. The mechanisms responsible for the improved glycemic control after bariatric surgery are the subject of ongoing research, and include increased circulating incretins stimulated by the delivery of nutrients to the intestine, contributing to weight loss and independently to glycemic control. The stomach is not always a villain, but is an ally in patients with type 2 diabetes.
引用
收藏
页码:285 / 287
页数:3
相关论文
共 15 条
[1]
BHARUCHA AE, 2008, CLIN ENDOCRINOL 0822
[2]
Gastric Accommodation and Emptying in Evaluation of Patients With Upper Gastrointestinal Symptoms [J].
Bredenoord, Albert J. ;
Chial, Heather J. ;
Camilleri, Michael ;
Mullan, Brian P. ;
Murray, Joseph A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2003, 1 (04) :264-272
[3]
Diabetic gastroparesis [J].
Camilleri, Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :820-829
[4]
Integrated upper gastrointestinal response to food intake [J].
Camilleri, Michael .
GASTROENTEROLOGY, 2006, 131 (02) :640-658
[5]
Gastrointestinal surgery as a treatment for diabetes [J].
Cummings, David E. ;
Flum, David R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03) :341-343
[6]
Adjustable gastric banding and conventional therapy for type 2 diabetes - A randomized controlled trial [J].
Dixon, John B. ;
O'Brien, Paul E. ;
Playfair, Julie ;
Chapman, Leon ;
Schachter, Linda M. ;
Skinner, Stewart ;
Proietto, Joseph ;
Bailey, Michael ;
Anderson, Margaret .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03) :316-323
[7]
Gastric emptying in diabetes: clinical significance and treatment [J].
Horowitz, M ;
O'Donovan, D ;
Jones, KL ;
Feinle, C ;
Rayner, CK ;
Samsom, M .
DIABETIC MEDICINE, 2002, 19 (03) :177-194
[8]
ASYMPTOMATIC GASTRIC RETENTION IN DIABETICS (GASTROPARESIS DIABETICORUM) [J].
KASSANDER, P .
ANNALS OF INTERNAL MEDICINE, 1958, 48 (04) :797-812
[9]
Gastrointestinal tract symptoms among persons with diabetes mellitus in the community [J].
Maleki, D ;
Locke, GR ;
Camilleri, M ;
Zinsmeister, AR ;
Yawn, BP ;
Leibson, C ;
Melton, LJ .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (18) :2808-2816
[10]
Targeting β-cell mass in type 2 diabetes:: Promise and limitations of new drugs based on incretins [J].
Salehi, Marzieh ;
Aulinger, Benedikt A. ;
D'Alessio, David A. .
ENDOCRINE REVIEWS, 2008, 29 (03) :367-379